| 26/02/26 | 07:00:09 | 26 Feb 2026 | | AstraZeneca prices a $2bn bond offering | RNS |
| 25/02/26 | 07:00:02 | 25 Feb 2026 | | Filing of Form 20-F with SEC | RNS |
| 24/02/26 | 11:00:01 | 24 Feb 2026 | | Annual Financial Report | RNS |
| 24/02/26 | 07:00:08 | 24 Feb 2026 | | Directorate change | RNS |
| 20/02/26 | 07:00:08 | 20 Feb 2026 | | Fixed-duration Calquence combo approved in US | RNS |
| 10/02/26 | 07:00:09 | 10 Feb 2026 | | Final Results | RNS |
| 03/02/26 | 07:00:07 | 3 Feb 2026 | | Update on Saphnelo subcutaneous administration | RNS |
| 02/02/26 | 15:00:00 | 2 Feb 2026 | | Total Voting Rights | RNS |
| 02/02/26 | 07:05:00 | 2 Feb 2026 | | Imfinzi recommended in EU for early gastric cancer | RNS |
| 02/02/26 | 07:00:09 | 2 Feb 2026 | | AstraZeneca begins trading on NYSE | RNS |
| 30/01/26 | 07:00:06 | 30 Jan 2026 | | AstraZeneca agrees obesity and T2D deal with CSPC | RNS |
| 29/01/26 | 09:51:51 | 29 Jan 2026 | | AstraZeneca invests $15bn in China through 2030 | RNS |
| 20/01/26 | 07:00:01 | 20 Jan 2026 | | AstraZeneca to complete direct listing on NYSE | RNS |
| 08/01/26 | 07:00:08 | 8 Jan 2026 | | AZN new Head of Investor Relations Joris Silon | RNS |
| 02/01/26 | 15:00:00 | 2 Jan 2026 | | Total Voting Rights | RNS |
| 22/12/25 | 11:00:00 | 22 Dec 2025 | | Director/PDMR Shareholding | RNS |
| 22/12/25 | 07:30:00 | 22 Dec 2025 | | Enhertu granted BTD for post-neoadjuvant early BC | RNS |
| 22/12/25 | 07:00:08 | 22 Dec 2025 | | Update on LATIFY Phase III trial of ceralasertib | RNS |
| 19/12/25 | 11:00:00 | 19 Dec 2025 | | Director/PDMR Shareholding | RNS |
| 16/12/25 | 07:05:00 | 16 Dec 2025 | | Subcutaneous Saphnelo approved in EU | RNS |
| 16/12/25 | 07:00:08 | 16 Dec 2025 | | Enhertu approved in US for 1L HER2+ metastatic BC | RNS |
| 04/12/25 | 15:00:00 | 4 Dec 2025 | | Holding(s) in Company | RNS |
| 01/12/25 | 15:05:00 | 1 Dec 2025 | | Block listing Interim Review | RNS |
| 01/12/25 | 15:00:00 | 1 Dec 2025 | | Total Voting Rights | RNS |
| 26/11/25 | 07:00:14 | 26 Nov 2025 | | Imfinzi approved in US for early gastric cancer | RNS |
| 24/11/25 | 07:00:11 | 24 Nov 2025 | | AstraZeneca manufacturing investment in Maryland | RNS |
| 20/11/25 | 07:00:15 | 20 Nov 2025 | | Koselugo (selumetinib) approved in the US | RNS |
| 17/11/25 | 15:00:01 | 17 Nov 2025 | | Holding(s) in Company | RNS |
| 14/11/25 | 11:00:00 | 14 Nov 2025 | | Director/PDMR Shareholding | RNS |
| 10/11/25 | 15:00:00 | 10 Nov 2025 | | Director/PDMR Shareholding | RNS |
| 06/11/25 | 07:00:10 | 6 Nov 2025 | | 9M and Q3 2025 results | RNS |
| 03/11/25 | 16:00:00 | 3 Nov 2025 | | Result of General Meeting | RNS |
| 03/11/25 | 15:00:01 | 3 Nov 2025 | | Total Voting Rights | RNS |
| 28/10/25 | 07:05:00 | 28 Oct 2025 | | Director Declaration | RNS |
| 28/10/25 | 07:00:09 | 28 Oct 2025 | | Koselugo (selumetinib) approved in the EU | RNS |
| 22/10/25 | 07:00:09 | 22 Oct 2025 | | Tezspire Approved in EU for CRSwNP | RNS |
| 20/10/25 | 07:05:00 | 20 Oct 2025 | | US FDA Approves Tezspire in CRSwNP | RNS |
| 20/10/25 | 07:00:05 | 20 Oct 2025 | | Positive CHMP opinion for subcutaneous Saphnelo | RNS |
| 13/10/25 | 07:00:05 | 13 Oct 2025 | | Agreement with US Govt to lower medicine prices | RNS |
| 07/10/25 | 07:00:09 | 7 Oct 2025 | | Baxdrostat met primary endpoint in Bax24 Ph3 trial | RNS |
| 06/10/25 | 07:30:01 | 6 Oct 2025 | | Datroway improved OS and PFS in TROPION-Breast02 | RNS |
| 01/10/25 | 15:00:01 | 1 Oct 2025 | | Total Voting Rights | RNS |
| 29/09/25 | 07:30:01 | 29 Sept 2025 | | Enhertu improved IDFS in early BC in DB-05 | RNS |
| 29/09/25 | 07:00:17 | 29 Sept 2025 | | AZN harmonises listing structure | RNS |
| 25/09/25 | 16:30:00 | 25 Sept 2025 | | Director/PDMR Shareholding | RNS |
| 22/09/25 | 07:05:00 | 22 Sept 2025 | | Koselugo recommended for EU approval | RNS |
| 22/09/25 | 07:00:12 | 22 Sept 2025 | | Tezspire Recommended for Approval in EU for CRSwNP | RNS |
| 17/09/25 | 07:05:00 | 17 Sept 2025 | | Saphnelo met primary endpoint in TULIP-SC | RNS |
| 17/09/25 | 07:00:12 | 17 Sept 2025 | | Update on RESOLUTE Phase III trial | RNS |
| 01/09/25 | 15:00:00 | 1 Sept 2025 | | Total Voting Rights | RNS |
